| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.081 | 0.08 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.068 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.08 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |